Table 1: Demographics of study population.

Demographics

 

Study Population n=138

Controls n=92

Cases n=46

P value

Male, n (%)

111 (80.4)

74 (80.4)

37 (80.4)

1.0

Age, years (mean, SD)

71.9 ± 9.74

71.2 ± 9.7

72.0 ± 9.9

0.94

BMI, kg/m2 (mean, SD)

29.3 ± 5.77

28.8 ± 5.4

30.1 ± 6.4

0.25

Ethnicity, n (%)

 

 

 

 

European

121 (87.7)

83 (90.2)

38 (82.6)

0.34

Maori & PI

12 (8.7)

7 (7.6)

5 (10.9)

 

Other

5 (3.6)

2 (2.2)

3 (6.5)

 

Risk Factors

 

 

 

 

 

Hypertension

126 (91.3)

84 (91.3)

42 (91.3)

1.0

Dyslipidaemia

116 (84.1)

78 (84.8)

38 (82.6)

0.74

Diabetes

66 (47.8)

41 (44.6)

25 (54.3)

0.28

Prior MI

64 (46.4)

42 (45.7)

22 (47.8)

0.81

Family Hx of CAD

35 (25.4)

26 (28.3)

9 (19.6)

0.27

Renal Dysfunction (eGFR<45)

17 (12.3)

9 (9.8)

8 (17.4)

0.20

Peripheral artery disease

20 (14.5)

12 (13)

8 (17.4)

0.50

Atrial Fibrillation

17 (12.3)

5 (5.4)

12 (26.1)

0.001

Stroke/TIA

16 (11.6)

9 (9.8)

7 (15.2)

0.35

Prior cardiac arrest

3 (2.2)

2 (2.2)

1 (2.2)

1.0

Smoking

 

 

 

 

Current

16 (11.6)

9 (9.8)

7 (15.2)

0.64

Former

68 (19.3)

46 (50)

22 (47.8)

 

Never

54 (39.1)

37 (40.2)

17 (37)

 

Clinical Presentation

 

 

 

 

 

STEMI

26 (18.8)

19 (20.7)

7 (15.2)

0.44

NSTEMI

112 (81.2)

73 (79.3)

39 (84.8)

 

Clinical Management

 

 

 

 

 

CABG

24 (17.4)

15 (16.3)

9 (19.6)

0.48

PCI

70 (50.7)

50 (54.3)

20 (43.5)

 

Medical

44 (31.9)

27 (29.3)

17 (37)

 

GRACE Score

 

139 ± 28.7

140 ± 27.8

139 ± 30.7

0.96